Insight Molecular Diagnostics (IMDX) Interest & Investment Income (2016 - 2017)

Insight Molecular Diagnostics' (IMDX) quarterly Interest & Investment Income came in at -$13000.0 in Q1 2017, down 425.0% year-on-year from $4000.0 in Q1 2016, and down 425.0% quarter-over-quarter from $4000.0 in Q1 2016.

Insight Molecular Diagnostics (IMDX) Interest & Investment Income (2016 - 2017) Analysis & Trends

Insight Molecular Diagnostics has disclosed Interest & Investment Income across 2 years of filings, most recently posting -$13000.0 for Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 6.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 233.00 Mn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn 27.00 Mn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn 597,000.00
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn 13.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 10.00 Mn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 11.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn -
10 Insight Molecular Diagnostics 4.34 Mn -24.59 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2017 -13,000.00
Mar 31, 2016 4,000.00